↑ トップへ ← 戻る

 Drug(薬物リスト) ALL | DrugBank 

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

72 / 12,172 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名(臨床試験情報から抽出)   DrugBank   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   Ac-203 1% topical ointment   -   -   -   -   1件:
162 
 2   Acetate   Acetate   -   -   -   40件:
1,
2,
6,
10,
13,
35,
40,
46,
49,
51,
60,
64,
70,
71,
73,
75,
76,
78,
81,
83,
85,
86,
88,
90,
96,
97,
113,
145,
156,
162,
171,
206,
222,
224,
225,
235,
265,
288,
298,
299 
 3   Arava   Leflunomide   D00749   1件: DHODH   1件: Pyrimidine metabolism   2件:
46,
162 
 4   Azathioprine   Azathioprine   D00238, D03033   -   -   18件:
11,
13,
19,
35,
42,
43,
44,
45,
46,
49,
65,
66,
85,
94,
95,
96,
97,
162 
 5   Azathioprine or mycophenolate mofetil   Azathioprine, Mycophenolic acid, Mycophenolate mofetil, mycophenolate mofetil   D00238, D00752, D03033, D05094, D05095, D05096   2件: IMPDH1, IMPDH2   1件: Purine metabolism   1件:
162 
 6   Bertilimumab   -   -   -   -   2件:
97,
162 
 7   Biv009   -   -   -   -   2件:
61,
162 
 8   Blood test   -   -   -   -   5件:
36,
86,
113,
162,
299 
 9   Carboxymethylcellulose   Carboxymethylcellulose   D07622   -   -   2件:
35,
162 
 10   Cellcept® in autoimmune bullous dermatoses   -   -   -   -   2件:
35,
162 
 11   Cellulose   Microcrystalline cellulose   D00093   -   -   2件:
35,
162 
 12   Clobetasol   Clobetasol   D07715   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   2件:
39,
162 
 13   Clobetasol 0.05% topical ointment   Clobetasol   D07715   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
162 
 14   Clobetasol propionate   Clobetasol, Clobetasol propionate, clobetasol propionate   D01272, D07715   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
162 
 15   Clobetasol propionate + methotrexate   Clobetasol, Clobetasol propionate, Methotrexate, clobetasol propionate   D00142, D01272, D02115, D07715   3件: DHFR, DHFR2, NR3C1   3件: Folate biosynthesis, Neuroactive ligand-receptor interaction, One carbon pool by folate   1件:
162 
 16   Clobetasol propionate alone   Clobetasol, Clobetasol propionate, clobetasol propionate   D01272, D07715   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
162 
 17   Clobetasol propionate cream treatment   Clobetasol, Clobetasol propionate, clobetasol propionate   D01272, D07715   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
162 
 18   Collagenase   Collagenase clostridium histolyticum   D09596   -   -   1件:
162 
 19   Cortancyl   Prednisone acetate, cortancyl   D00068, D02798, D04855, D06542, D08416   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   3件:
35,
41,
162 
 20   Cortancyl 20 mg   Prednisone acetate, cortancyl   D00068, D02798, D04855, D06542, D08416   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   2件:
35,
162 
 21   Cotton   Cotton   -   -   -   2件:
35,
162 
 22   Cultivated oral mucosal epithelial sheet transplantation   -   -   -   -   2件:
38,
162 
 23   Cyclophosphamide   Cyclophosphamide   D00287, D07760   -   -   43件:
13,
14,
16,
19,
20,
26,
28,
35,
36,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
52,
56,
60,
61,
62,
65,
66,
84,
85,
93,
96,
162,
164,
172,
222,
224,
265,
274,
283,
284,
285,
288,
326,
331 
 24   Cyclophosphamide 50mg oral tablet   Cyclophosphamide   D00287, D07760   -   -   1件:
162 
 25   Cyclosporine   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   33件:
11,
14,
19,
20,
28,
36,
40,
41,
42,
45,
46,
49,
50,
53,
56,
58,
60,
62,
64,
65,
90,
95,
97,
162,
164,
222,
226,
228,
234,
283,
284,
285,
302 
 26   Data report   -   -   -   -   1件:
162 
 27   Dermoval   -   -   -   -   2件:
35,
162 
 28   Df2156a   -   -   -   -   1件:
162 
 29   Doxycycline   Doxycycline   D00307, D02129, D03903, D03904, D07876   -   -   15件:
13,
23,
28,
46,
84,
85,
89,
96,
97,
158,
162,
167,
227,
280,
299 
 30   Halometasone   Halometasone   D07202   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
162 
 31   Imatinib   Imatinib   D01441, D08066   3件: ABL1, KIT, PDGFRA   3件: Chronic myeloid leukemia, MAPK signaling pathway, Pathways in cancer   11件:
13,
28,
34,
35,
46,
51,
85,
86,
87,
89,
162 
 32   Infliximab   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   22件:
35,
37,
38,
39,
40,
41,
43,
45,
46,
49,
50,
56,
65,
84,
95,
96,
97,
98,
162,
164,
269,
271 
 33   Ixekizumab   Ixekizumab   D10071   1件: IL17A   2件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway   4件:
37,
162,
269,
271 
 34   Ladarixin   -   -   -   -   1件:
162 
 35   Mabthera   -   -   -   -   15件:
11,
13,
35,
46,
50,
51,
53,
61,
63,
64,
65,
83,
162,
222,
271 
 36   Mabthéra   -   -   -   -   2件:
35,
162 
 37   Mathéra   -   -   -   -   2件:
35,
162 
 38   Mepolizumab   Mepolizumab   D04923   1件: IL5   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   4件:
44,
45,
98,
162 
 39   Mepolizumab (a-il-5 antibody)   Mepolizumab   D04923   1件: IL5   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   1件:
162 
 40   Methotrexate   Methotrexate   D00142, D02115   2件: DHFR, DHFR2   2件: Folate biosynthesis, One carbon pool by folate   33件:
11,
13,
19,
34,
35,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
55,
56,
60,
62,
65,
84,
93,
96,
97,
162,
164,
172,
256,
271,
284,
285,
326,
331 
 41   Minocycline   Minocycline   D00850, D05045   -   -   13件:
2,
6,
8,
13,
46,
85,
90,
94,
162,
201,
206,
280,
299 
 42   Mitomycin   Mitomycin   D00208   -   -   3件:
94,
162,
329 
 43   Mycophenolate   Mycophenolic acid   D05096   2件: IMPDH1, IMPDH2   1件: Purine metabolism   33件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
84,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 44   Mycophenolate mofetil   Mycophenolic acid, Mycophenolate mofetil, mycophenolate mofetil   D00752, D05094, D05095, D05096   2件: IMPDH1, IMPDH2   1件: Purine metabolism   32件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 45   Myfortic 180 mg   -   -   -   -   1件:
162 
 46   Myfortic 180 mg filmtabletten   -   -   -   -   1件:
162 
 47   Nicotinamide   Nicotinamide   D00036   -   -   3件:
6,
49,
162 
 48   Npb-01   -   -   -   -   3件:
13,
14,
162 
 49   Omalizumab   Omalizumab   D05251   1件: FCER1A   2件: Asthma, Fc epsilon RI signaling pathway   6件:
53,
65,
98,
162,
226,
299 
 50   Petrolatum   Petrolatum   D05304, D05331   -   -   3件:
35,
158,
162 
 51   Prednisolone   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   38件:
11,
13,
25,
26,
35,
38,
39,
41,
43,
44,
45,
46,
49,
50,
51,
56,
60,
61,
63,
64,
65,
66,
75,
81,
84,
85,
95,
96,
97,
113,
145,
162,
222,
269,
271,
296,
299,
300 
 52   Prednisone   Ethanol   D00068, D02798, D04855, D06542   -   -   43件:
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
61,
63,
64,
65,
66,
81,
84,
85,
86,
95,
96,
97,
113,
162,
164,
222,
224,
228,
251,
283,
284,
285,
288,
299,
300,
331 
 53   Qge031   -   -   -   -   1件:
162 
 54   Restasis   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   2件:
53,
162 
 55   Riboflavin   Riboflavin   D00050, D01622, D01913   -   -   8件:
13,
38,
46,
96,
97,
162,
168,
265 
 56   Rituximab   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   42件:
11,
13,
14,
17,
35,
36,
43,
44,
45,
46,
49,
50,
51,
52,
53,
56,
60,
61,
63,
64,
65,
66,
83,
84,
85,
86,
93,
94,
96,
97,
162,
222,
223,
229,
256,
271,
283,
284,
285,
288,
300,
331 
 57   Rituximab 1g iv   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   1件:
162 
 58   Rituximab combined with omalizumab   Omalizumab, Rituximab   D02994, D05251   2件: FCER1A, MS4A1   3件: Asthma, Fc epsilon RI signaling pathway, Hematopoietic cell lineage   1件:
162 
 59   Rva576   -   -   -   -   3件:
62,
109,
162 
 60   Silver   Silver   -   -   -   2件:
35,
162 
 61   Simvastatin   Simvastatin   D00434   1件: HMGCR   1件: Terpenoid backbone biosynthesis   19件:
6,
13,
15,
34,
46,
49,
51,
66,
79,
86,
89,
94,
158,
162,
195,
265,
298,
299,
310 
 62   Simvastatin-ratiopharm   Simvastatin   D00434   1件: HMGCR   1件: Terpenoid backbone biosynthesis   1件:
162 
 63   Simvastatin-ratiopharm®   Simvastatin   D00434   1件: HMGCR   1件: Terpenoid backbone biosynthesis   1件:
162 
 64   Solu-medrone   -   -   -   -   3件:
51,
83,
162 
 65   Topical infliximab   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   3件:
38,
39,
162 
 66   Treatment systemic therapy (prednisone)   Ethanol   D00068, D02798, D04855, D06542   -   -   1件:
162 
 67   Treatment with systemic therapy (doxycycline)   Doxycycline   D00307, D02129, D03903, D03904, D07876   -   -   1件:
162 
 68   Treatment with systemic therapy (methotrexate)   Methotrexate   D00142, D02115   2件: DHFR, DHFR2   2件: Folate biosynthesis, One carbon pool by folate   1件:
162 
 69   Treatment with systemic therapy (prednisone)   Ethanol   D00068, D02798, D04855, D06542   -   -   1件:
162 
 70   Treatment with topical superpotent corticosteroid therapy   -   -   -   -   1件:
162 
 71   Tripterygium   Tripterygium wilfordii whole   -   -   -   8件:
46,
66,
67,
96,
162,
222,
224,
271 
 72   Ustekinumab   Ustekinumab   D09214   3件: IL12A, IL12B, IL23A   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   15件:
37,
41,
46,
49,
50,
53,
56,
65,
84,
93,
96,
97,
162,
269,
271 

先頭へ